Results 211 to 220 of about 425,317 (330)
Coordinating therapy with gene expression kinetics emerges as a key strategy for maximizing nanomedicine efficacy in aggressive cancers. A hybrid nanocarrier delivering HSP70‐targeting siRNA demonstrates this chronotherapeutic principle through systematic cellular profiling.
Tianliang Fang +6 more
wiley +1 more source
Forkhead box protein C2 (FOXC2) is highlighted as a pivotal effector in postoperative peritoneal adhesion (PPA) formation. Mechanically, FOXC2 mediates NETs‐induced EMT alterations through the TGF‐β1‐Smad2/3 pathway. Aloe‐emodin (AE) ameliorates FOXC2‐driven fibrosis by blocking NETs formation and EMT changes through this pathway.
Lili Yang +10 more
wiley +1 more source
"Abstracts of the 78th Annual Meeting of the Japanese Cancer Association; 2019 Sept 26-28; Kyoto, Japan" as Cancer Science, Supplement 1, Vol 110 (2019). [PDF]
europepmc +1 more source
Changes in Stand Structure after the Mass Mortality of Oak Trees in Keihoku Area, Kyoto City, Japan
Hiroki Itô +2 more
openalex +2 more sources
The development of multiferroic heterostructures with a half‐metallic property is one of the key technologies for electric‐field operatable magnonic devices. In this study, Co2FeSi/LiNbO3 multiferroic heterostructures with a low damping constant are experimentally developed and an electric‐field modulation of its magnetization dynamics is demonstrated.
Shinya Yamada +7 more
wiley +1 more source
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He +17 more
wiley +1 more source
Abstracts from the 50th Congress of the International Society of Paediatric Oncology (SIOP) Kyoto, Japan November 16-19, 2018. [PDF]
europepmc +1 more source

